pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·6h ago·1 min read
save

Quest Diagnostics reports cyberattack that may have exposed patient records

Oct 22, 2026·read at Fierce Biotech ↗RegulatoryNegative

Quest Diagnostics disclosed in an SEC filing that its Quanum LSM system was accessed without authorization on Oct 21, potentially compromising patient data.

The breach affected a system used by certain clients to order tests and view results, and the company believes an unauthorized party accessed some patient records, though the number of records is unknown.

Quest has engaged external cybersecurity experts and notified federal law enforcement, stating the incident has not materially disrupted its operations or ability to serve patients.

The attack adds Quest to a growing list of medtech firms hit by cyber incidents this year, including Novocure, Boston Scientific, Medtronic, Stryker, Abbott and iRhythm.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Quest Diagnostics’ test results system breached in yet another medtech cyberattack”

read at Fierce Biotech ↗
268 words · retrieved 39m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
BOSTON SCIENTIFIC CORP2
topics
Diagnostics Company9Medical Device Company8

related stories

  • Sep 1Boston Scientific halts sales of angiographic catheters amid 2 serious injuriesFierce Biotech
  • Aug 26Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its businessFierce Biotech
  • Aug 24Qiagen appoints new chief executive after 9-month searchFierce Biotech
  • Aug 24Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood testFierce Biotech
  • Aug 18Craif raises $33M to boost work on its urine test for cancerFierce Biotech